Globeimmune

GBIM · OTC

$0.0001+$0.00 (+0.00%)TodayMarket closed · Sep 29, 3:48 PM ET

No price history for this range.

About GBIM

GlobeImmune, Inc. is a biopharmaceutical company. The company is headquartered in Louisville, Colorado. The company went IPO on 2014-07-02. The firm is focused on developing products for the treatment of cancer and infectious diseases based on its Tarmogen platform. The Company’s Tarmogen platform activates the immune system by stimulating a subset of white blood cells called T cells that destroy infected or malignant cells in contrast to traditional vaccines, which predominately stimulate antibody production. Tarmogens also reduce the number and function of regulatory T cells, thus further enabling the antigen-specific cellular immune response. The company has over two Tarmogen product candidates in clinical evaluation for infectious disease and multiple cancer indications. The firm's oncology product candidates include GI-6301, GI-6207 and GI-4000. The firm's infectious disease product candidates include GS-4774, GI-19000, GI-2010 and GI-18000.

Employees: 0
Headquarters: Louisville, Colorado
Listed: Jul 2, 2014
Sector: Health Care
Industry: Biotechnology
Website: globeimmune.com

Leadership

Globeimmune executives
Name	Title	Since	Age
J. William Freytag	—	—	—
Timothy Rodell	—	2003	70
C. Jeffrey Dekker	—	—	56
Augustine Lawlor	—	—	65
Daniel Mitchell	—	—	64
S. Edward Torres	—	—	58
Susan Noonan	—	—	—

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Globeimmune suppliers and customers
Company	Relationship	Country	Correlation
Gilead Sciences GILD	Supplier and customer	US	0.52
ImmunityBio IBRX	Supplier and customer	US	0.07
Bristol-Myers Squibb BMY	Supplier and customer	US	-0.73
United States	Supplier and customer	US	—
University of Colorado	Supplier and customer	US	—
Colorado State University	Supplier and customer	US	—
Georgetown University	Supplier and customer	US	—
Memorial Sloan-Kettering Cancer Center	Supplier and customer	US	—

Similar companies

Companies in the same industry as Globeimmune

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.